Getting the message across: Pathophysiology and signaling via receptors for polypeptide hormones and proteinases

Clinical and Investigative Medicine

Volumn 33, Issue 2, 2010, Pages

  Hollenberg, Morley D ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE HYDROLASE; PROTEINASE ACTIVATED RECEPTOR; RECEPTOR;

ANIMAL; ARTICLE; HUMAN; INFLAMMATION; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; INFLAMMATION; PEPTIDE HYDROLASES; RECEPTORS, PEPTIDE; RECEPTORS, PROTEINASE-ACTIVATED; SIGNAL TRANSDUCTION;

EID: 77951863416     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Hollenberg, M.D., Hope, D.B.The isolation of the native hormone-binding proteins from bovine pituitary posterior lobes. Crystallization of neurophysin-I and-II as complexes with [8-arginine]-vasopressin. Biochem J 1968:106:557-64
2. Steiner, D.F., Cunningham, D., Spigelman, L., Aten, B. Insulin biosynthesis: evidence for a precursor. Science 1967:157:697-700.
3. Cuatrecasas, P. Perturbation of the insulin receptor of isolated fat cells with proteolytic enzymes. J. Biol. Chem. 1971:246:6522-31.
4. Cuatrecasas, P. Interaction of insulin with the cell membrane: the primary action of insulin. Proc Natl Acad Sci USA 1969:63:450-57.
5. Kono, T., Barham, F.W. Insulin-like effects of trypsin on fat cells. Localization of the metabolic steps and the cellular site affected by the enzyme. J Biol Chem 1971:246:6204-09.
6. Rieser, P., Rieser, C.H. Anabolic responses of diaphragm muscle to insulin and to other pancreatic proteins. Proc Soc Exp Biol Med 1964:116:669-71.
7. Rieser, P. The insulin-like action of pepsin and pepsinogen. Acta Endocrinol (Copenh) 1967:54:375.
8. Shoelson, S.E., White, M.F., Kahn, C.R. Tryptic activation of the insulin receptor. Proteolytic truncation of the alpha-subunit releases the beta-subunit from inhibitory control. J Biol Chem 1988:263:4852-60.
9. Carney, D.H., Cunningham, D.D. Initiation of check cell division by trypsin action at the cell surface. Nature 1977:268:602-06.
10. Carney, D.H., Cunningham, D.D. Transmembrane action of thrombin initiates chick cell division. J Supramol Struct 1978:9:350-57.
11. Carpenter, G., King, L.Jr., Cohen, S. Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro. Nature 1978:276:409-10. (Pubitemid 9096475)
12. Ushiro, H., Cohen, S. Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes. J Biol Chem 1980:255:8363-65.
13. Petruzzelli, L.M., Ganguly, S., Smith, C.J., Cobb, M.H., Rubin, C.S., Rosen, O.M. Insulin activates a tyrosine-specific protein kinase in extracts of 3T3-L1 adipocytes and human placenta. Proc Natl Acad Sci U S A 1983:79:6792-96.
14. Petruzzelli, L., Herrera, R., Rosen, O.M. Insulin receptor is an insulin-dependent tyrosine protein kinase: copurification of insulin-binding activity and protein kinase activity to homogeneity from human placenta. Proc Natl Acad Sci U S A 1984:81:3327-31.
15. Muramatsu, I., Hollenberg, M.D., Lederis, K. Vascular actions of epidermal growth factor-urogastrone: possible relationship to prostaglandin production. Can J Physiol Pharmacol 1985:63:994-9.
16. Hollenberg, M.D., Muramatsu, I., Itoh, H., Patel, P., Yang, S.G., Lederis, K. Contractile actions of epidermal growth factor-urogastrone in isolated smooth muscle preparations from guinea pig stomach: structure- activity relationships and comparison with the effects of human transforming growth factor-alpha. J Pharmacol Exp Ther 1989:248:384-90.
17. Vu, T.K., Hung, D.T., Wheaton, V.I., Coughlin, S.R. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991:64:1057-68.
18. Muramatsu, I., Laniyonu, A., Moore, G.J., Hollenberg, M.D. Vascular actions of thrombin receptor peptide. Can J Physiol Pharmacol 1992:70:996-1003.
19. Hollenberg, M.D., Yang, S.G., Laniyonu, A.A., Moore, G.J., Saifeddine, M. Action of thrombin receptor polypeptide in gastric smooth muscle: identification of a core pentapeptide retaining full thrombin-mimetic intrinsic activity. Mol Pharmacol 1992:42:186-91.
20. Zheng, X.L., Renaux, B., Hollenberg, M.D. Parallel contractile signal transduction pathways activated by receptors for thrombin and epidermal growth factor-urogastrone in guinea pig gastric smooth muscle: blockade by inhibitors of mitogen-activated protein kinase-kinase and phosphatidyl inositol 3'-kinase. J Pharmacol Exp Ther 1998:285:325-34.
21. Prenzel, N., Zwick, E., Daub, H., Leserer, M., Abraham, R., Wallasch, C., Ullrich, A. EGF receptor trans- activation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 1999:402:884-88.
22. Laumonnier, Y., Syrovets, T., Burysek, L., Simmet, T. Identification of the annexin A2 heterotetramer as a receptor for the plasmin-induced signaling in human peripheral monocytes. Blood 2006:107:3342-49.
23. Bar-Shavit, R., Kahn, A., Mudd, M.S., Wilner, G.D., Mann, K.G., Fenton, J.W. 2nd. Localization of a che- motactic domain in human thrombin. Biochemistry 1984:23:397-400.
24. Bar-Shavit, R., Kahn, A.J., Mann, K.G., Wilner, G.D. Growth-promoting effects of esterolytically inactive thrombin on macrophages. J Cell Biochem 1986:32:261-72.
25. Glenn KC, Frost GH, Bergmann JS, Carney DH. Synthetic peptides bind to high-affinity thrombin receptors and modulate thrombin mitogenesis. Pept Res. 1988:1:65-73.
26. Rasmussen, U.B., Vouret-Craviari, V., Jallat, S., Schlesinger, Y., Pages, G., Pavirani, A., Lecocq, J.P., Pouyssegur, J., Van Obberghen-Schilling, E. cDNA cloning and expression of a hamster alpha-thrombin receptor coupled to Ca2+ mobilization. FEBS Lett 1991:288:123-28.
27. Sabo, T., Gurwitz, D., Motola, L., Brodt, P., Barak, R., Elhanaty, E. Structure-activity studies of the thrombin receptor activating peptide. Biochem Biophys Res Commun 1992:188:604-10.
28. Scarborough, R.M., Naughton, M.A., Teng, W., Hung, D.T., Rose, J., Vu, T.K., Wheaton, V.I., Turck, C.W., Coughlin, S.R. Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function. J Biol Chem 1992:267:13146-49.
29. Hollenberg, M.D., Laniyonu, A.A., Saifeddine, M., Moore, G.J. Role of the amino- and carboxyl-terminal domains of thrombin receptor-derived polypeptides in biological activity in vascular endothelium and gastric smooth muscle: evidence for receptor subtypes. Mol Pharmacol 1993:43:921-30.
30. Laniyonu, A.A., Hollenberg, M.D. Vascular actions of thrombin receptor-derived polypeptides: structure- activity profiles for contractile and relaxant effects in rat aorta. Br J Pharmacol 1995:114:1680-86.
31. Hollenberg, M.D., Saifeddine, M., al-Ani, B., Kawabata, A. Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides. Can J Physiol Pharmacol 1997:75:832-41.
32. Ahlquist, R.P. A study of the adrenotropic receptors. Am J Physiol 1948:153:586-600.
33. Coughlin, S.R. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 2005:3:1800-14.
34. Hollenberg, M.D., Compton, S.J. International Union of Pharmacology. XXVIII. Proteinase-activated receptors. Pharmacol Rev 2002:54:203-17.
35. Nystedt, S., Emilsson, K., Wahlestedt, C., Sundelin, J. Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci U S A 1994:91(20):9208-12.
36. Al-Ani, B., Saifeddine, M., Hollenberg, M.D. Detection of functional receptors for the proteinase- activated-receptor-2-activating polypeptide, SLIGRL- NH2, in rat vascular and gastric smooth muscle. Can J Physiol Pharmacol 1995:73:1203-07.
37. Kinlough-Rathbone, R.L., Rand, M.L., Packham, M.A. Rabbit and rat platelets do not respond to thrombin receptor peptides that activate human platelets. Blood 1993:82:103-06.
38. Kahn, M.L., Zheng, Y.W., Huang, W., Bigornia, V., Zeng, D., Moff, S., Farese, R.V. Jr., Tam, C., Coughlin, S.R. A dual thrombin receptor system for platelet activation. Nature 1998:394:690-94.
39. Kawabata, A., Saifeddine, M., Al-Ani, B., Leblond, L., Hollenberg, M.D. Evaluation of proteinase-activated receptor-1 (PAR1) agonists and antagonists using a cultured cell receptor desensitization assay: activation of PAR2 by PAR1-targeted ligands. J Pharmacol Exp Ther 288:358-70.
40. 40. Dulon, S., Candé, C., Bunnett, N.W., Hollenberg, M.D., Chignard, M., Pidard, D. Proteinase-activated receptor-2 and human lung epithelial cells: disarming by neutrophil serine proteinases. Am J Respir Cell Mol Biol 2003:28:339-46.
41. Compton, S.J., Sandhu, S., Wijesuriya, S.J., Hollenberg, M.D. Glycosylation of human proteinase- activated receptor-2 (hPAR2): role in cell surface expression and signalling. Biochem J 2002:368(Pt2):495-505.
42. De Mey, J.G., Claeys, M., Vanhoutte, P.M. Endothelium-dependent inhibitory effects of acetylcho- line, adenosine triphosphate, thrombin and arachidonic acid in the canine femoral artery. J Pharmacol Exp Ther 1982:222:166-73.
43. Haver, V.M., Namm, D.H. Generation of a vasoactive substance in human plasma during coagulation. Evidence of thrombin-induced contraction of rabbit aorta and dog coronary artery. Blood Vessels 1983:20:92-98.
44. McGuire, J.J., Dai, J., Andrade-Gordon, P., Triggle, C.R., Hollenberg, M.D. Proteinase-activated receptor-2 (PAR2): vascular effects of a PAR2-derived activating peptide via a receptor different than PAR2. J Pharmacol Exp Ther 2002:303:985-92.
45. Rioux, K.P., Wallace, J.L. Long-term antigen challenge results in progressively diminished mucosal mast cell degranulation in rats. Gastroenterology 1996:111:1516-1523.
46. Vergnolle, N., Hollenberg, M.D., Wallace, J.L. Pro- and anti-inflammatory actions of thrombin: a distinct role for proteinase-activated receptor-1 (PAR1). Br J Pharmacol 1999:126:1262-68.
47. Vergnolle, N., Hollenberg, M.D., Sharkey, K.A., Wallace, J.L. Characterization of the inflammatory response to proteinase-activated receptor-2 (PAR2)-activating peptides in the rat paw. Br J Pharmacol 1999:127:1083-90.
48. Cenac, N., Coelho, A.M., Nguyen, C., Compton, S., Andrade-Gordon, P., MacNaughton, W.K., Wallace, J.L., Hollenberg, M.D., Bunnett, N.W., Garcia-Villar, R., Bueno, L., Vergnolle, N. Induction of intestinal inflammation in mouse by activation of proteinase- activated receptor-2. Am J Pathol 2002:161:1903-15.
49. Steinhoff, M., Vergnolle, N., Young, S.H., Tognetto, M., Amadesi, S., Ennes, H.S., Trevisani, M., Hollenberg, M.D., Wallace, J.L., Caughey, G.H., Mitchell, S.E., Williams, L.M., Geppetti, P., Mayer, E.A., Bunnett, N.W. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 2000:6:151-58.
50. Vergnolle, N., Bunnett, N.W., Sharkey, K.A., Brussee, V., Compton, S.J., Grady, E.F., Cirino, G., Gerard, N., Basbaum, A.I., Andrade-Gordon, P., Hollenberg, M.D., Wallace, J.L. Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway. Nat Med 2001:7:821-26.
51. Ramachandran, R., Mihara, K., Mathur, M., Rochdi, M.D., Bouvier, M., Defea, K., Hollenberg, M.D. Agonist-biased signaling via proteinase activated receptor-2: differential activation of calcium and mitogen-activated protein kinase pathways. Mol Pharmacol 2009:76:791-801.
52. Al-Ani, B., Hansen, K.K., Hollenberg, M.D. Proteinase-activated receptor-2: key role of amino- terminal dipeptide residues of the tethered ligand for receptor activation. Mol Pharmacol 2004:65:149-
53. Hansen, K.K., Sherman, P.M., Cellars, L., Andrade-Gordon, P., Pan, Z., Baruch, A., Wallace, J.L., Hollenberg, M.D., Vergnolle, N. A major role for proteolytic activity and proteinase-activated receptor-2 in the pathogenesis of infectious colitis. Proc Natl Acad Sci U SA 2005:102:8363-68.
54. Ferrell, W.R., Lockhart, J.C., Kelso, E.B., Dunning, L., Plevin, R., Meek, S.E., Smith, A.J., Hunter, G.D., McLean, J.S., McGarry, F., Ramage, R., Jiang, L., Kanke, T., Kawagoe, J. Essential role for proteinase- activated receptor-2 in arthritis. J Clin Invest 2003:111:35-41.
55. Kelso, E.B., Lockhart, J.C., Hembrough, T., Dunning, L., Plevin, R., Hollenberg, M.D., Sommerhoff, C.P., McLean, J.S., Ferrell, W.R. Therapeutic promise of proteinase-activated receptor-2 antagonism in joint inflammation. J Pharmacol Exp Ther 2006:316:1017-24.
56. Ebeling, C., Lam, T., Gordon, J.R., Hollenberg, M.D., Vliagoftis, H. Proteinase-activated receptor-2 promotes allergic sensitization to an inhaled antigen through a TNF-mediated pathway. J Immunol 2007:179:2910-17.
57. Noorbakhsh, F., Tsutsui, S., Vergnolle, N., Boven, L.A., Shariat, N., Vodjgani, M., Warren, K.G., Andrade-Gordon, P., Hollenberg, M.D., Power, C. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J Exp Med 2006:203:425-35.
58. Adam, E., Hansen, K.K., Astudillo Fernandez, O., Coulon, L., Bex, F., Duhant, X., Jaumotte, E., Hollen- berg, M.D., Jacquet, A. The house dust mite allergen Der p 1, unlike Der p 3, stimulates the expression of interleukin-8 in human airway epithelial cells via a proteinase-activated receptor-2-independent mechanism. J Biol Chem 2006:281:6910-23.
59. Sun, G., Stacey, M.A., Schmidt, M., Mori, L., Mattoli, S. Interaction of mite allergens Der p3 and Der p9 with protease-activated receptor-2 expressed by lung epithelial cells. J Immunol 2001:167:1014-21.
60. Dulon., S., Leduc, D., Cottrell, G.S., D'Alayer, J., Hansen, K.K., Bunnett, N.W., Hollenberg, M.D., Pidard, D., Chignard, M. Pseudomonas aeruginosa elastase disables proteinase-activated receptor 2 in respiratory epithelial cells. Am J Respir Cell Mol Biol 2005:32:411-19.
61. Khoufache, K., LeBouder, F., Morello, E., Laurent, F., Riffault, S., Andrade-Gordon, P., Boullier, S., Rousset, P., Vergnolle, N., Riteau, B. Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-gamma-dependent pathway. J Immunol 2009:182:7795-7802.
62. Maryanoff B.E., Zhang H.C., Andrade-Gordon P., Derian C.K. Discovery of potent peptide-mimetic antagonists for the human thrombin receptor, protease- activated receptor-1 (PAR-1). Curr Med Chem Cardiovasc Hematol Agents 2003:1:13-36.
63. Fiorucci, S., Mencarelli, A., Palazzetti, B., Distrutti, E., Vergnolle, N., Hollenberg, M.D., Wallace, J.L., Morelli, A., Cirino G. Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis. Proc Natl Acad Sci USA 2001:98:13936-13941.
64. Ramachandran R., Hollenberg M.D. Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more. Br J Pharmacol. 2008:153: Suppl 1:S263-82.
65. Hollenberg MD, Saifeddine M, Sandhu S, Houle S, Vergnolle N. Proteinase-activated receptor-4: evaluation of tethered ligand-derived peptides as probes for receptor function and as inflammatory agonists in vivo. Br J Pharmacol. 2004:143:443-54.
66. Oikonomopoulou K, Hansen KK, Saifeddine M, Tea I, Blaber M, Blaber SI, Scarisbrick I, Andrade-Gordon P, Cottrell GS, Bunnett NW, Diamandis EP, Hollenberg MD. Proteinase-activated receptors, targets for kallik- rein signaling. J Biol Chem. 2006::281:32095-32112.
67. Houle S, Papez MD, Ferazzini M, Hollenberg MD, Vergnolle N. Neutrophils and the kallikrein-kinin system in proteinase-activated receptor 4-mediated inflammation in rodents. Br J Pharmacol. 2005:146:670-8.
68. Knecht W, Cottrell GS, Amadesi S, Mohlin J, Skaregarde A, Gedda K, Peterson A, Chapman K, Hollenberg MD, Vergnolle N, Bunnett NW. Trypsin IV or mesotrypsin and p23 cleave protease-activated receptors 1 and 2 to induce inflammation and hyperalgesia. J Biol Chem. 2007:282:26089-100.
69. Nguyen C, Coelho AM, Grady E, Compton SJ, Wallace JL, Hollenberg MD, Cenac N, Garcia-Villar R, Bueno L, Steinhoff M, Bunnett NW, Vergnolle N. Colitis induced by proteinase-activated receptor-2 agonists is mediated by a neurogenic mechanism. Can J Physiol Pharmacol. 2003:81:920-7.
70. Hansen KK, Sherman PM, Cellars L, Andrade-Gordon P, Pan Z, Baruch A, Wallace JL, Hollenberg MD, Vergnolle N. A major role for proteolytic activity and proteinase-activated receptor-2 in the pathogenesis of infectious colitis. Proc Natl Acad Sci U S A. 2005:102:8363-8368.
71. Saifeddine M, Al-Ani B, Sandhu S, Wijesuriya SJ, Hollenberg MD. Contractile actions of proteinase- activated receptor-derived polypeptides in guinea-pig gastric and lung parenchymal strips: evidence for distinct receptor systems. Br J Pharmacol. 2001:132:556-66.
72. Kawabata A, Kubo S, Ishiki T, Kawao N, Sekiguchi F, Kuroda R, Hollenberg MD, Kanke T, Saito N. Proteinase-activated receptor-2-mediated relaxation in mouse tracheal and bronchial smooth muscle: signal transduction mechanisms and distinct agonist sensitivity. J Pharmacol Exp Ther. 2004: 311:402-410.
73. Hansen KK, Oikonomopoulou K, Li Y, Hollenberg MD. Proteinases, proteinase-activated receptors (PARs) and the pathophysiology of cancer and diseases of the cardiovascular, musculoskeletal, nervous and gastrointestinal systems. Naunyn Schmiedebergs Arch Pharmacol. 2008:377:377-392.